Key result
18F-FDG PET/CT successfully identified pulmonary lymphangitic carcinomatosis without concurrent liver metastasis in a 66-year-old man with a history of colon cancer.
Why the study?
Pulmonary lymphangitic carcinomatosis represents a rare presentation of pulmonary metastases involving tumor cell infiltration into the pulmonary lymphatic system.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
18F-FDG PET/CT is a valuable noninvasive tool for identifying rare pulmonary lymphangitic carcinomatosis and guiding biopsy in patients with colon cancer.
RATIONALE: The infiltration of tumor cells to pulmonary lymphatic system, as known as pulmonary lymphangitis carcinomatosis (PLC), is a rare presentation of pulmonary metastases. PATIENT CONCERNS: We reported a case of a 66-year-old man after surgery, chemotherapy, and radiation therapy for colon cancer. Two months after these therapies, the patient complained of nonproductive cough for 1 week. DIAGNOSES: 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) scanning revealed increased FDG uptake along the thickened bronchovascular bundles, in bilaterally scattered ground-glass opacities and in mediastinal lymphadenopathy. The transbronchial biopsy and pathological study confirmed the diagnosis of PLC. INTERVENTIONS: Antineoplastic treatment (cetuximab) were administered after the patient was diagnosed with PLC. OUTCOMES: The patient died of respiratory failure within 3 months after the onset of his symptom. LESSONS: 18F-FDG PET/CT play an important role in identifying PLC, in selecting possible biopsy sites, and in accessing the extent of metastatic disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) conducted a case report in Pulmonary lymphangitic carcinomatosis from colon cancer (n=1). 18F-FDG PET/CT was evaluated on Diagnosis of pulmonary lymphangitic carcinomatosis. 18F-FDG PET/CT successfully identified pulmonary lymphangitic carcinomatosis without concurrent liver metastasis in a 66-year-old man with a history of colon cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: